STANFORD UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Ashvattha Therapeutics Unveils Novel Nanomedicine Radiotracers for Neuroinflammation and Cancer Imaging at SNMMI 2025
Ashvattha Therapeutics will present data on two breakthrough nanomedicine radiotracers at the SNMMI Annual Meeting, demonstrating selective targeting capabilities in neuroinflammation and cancer.
Fujirebio Partners with Stanford Medicine to Advance Ultrasensitive Infectious Disease Diagnostics
Fujirebio has announced a strategic collaboration with Stanford Medicine to accelerate research and innovation in infectious disease testing using ultrasensitive immunoassays.
FDA Approves First Drug-Free Wearable Device for Pediatric Nasal Congestion Treatment
The FDA has approved an expanded pediatric indication for the SONU Band, making it the first FDA-approved, drug-free solution for nasal congestion and allergies in children aged 12 years and older.
Continuity Biosciences Acquires Focal Medical to Advance Iontophoresis-Based Pancreatic Cancer Therapy
Continuity Biosciences has acquired Focal Medical, a North Carolina-based company developing site-specific chemotherapy using iontophoresis technology for pancreatic cancer treatment.
Matter Neuroscience Partners with Stanford Medicine to Test Novel fMRI-Guided Depression Therapy
Matter Neuroscience has announced a collaboration with Stanford Medicine to conduct a controlled, multi-arm study enrolling at least 210 depressed patients using real-time 7T fMRI neurofeedback combined with the Matter protocol.
Stanford Medicine Gene Therapy Skin Grafts Show 81% Healing Rate in Phase 3 Epidermolysis Bullosa Trial
Stanford Medicine-led phase 3 trial demonstrates gene therapy skin grafts achieved 81% healing in epidermolysis bullosa wounds compared to 16% with standard care after 24 weeks.
Precision Medicine Breakthrough Shows 2.6-Fold Survival Improvement in Deadly Canine Cancer
FidoCure and Stanford researchers have published groundbreaking findings showing targeted therapies significantly improve survival rates in dogs with splenic hemangiosarcoma, the deadliest canine cancer.
Valinor Discovery Emerges from Stealth with AI Platform to Simulate Drug Efficacy Before Clinical Trials
Valinor Discovery has launched an AI-powered platform that simulates patient responses to therapies before clinical testing, with initial applications in oncology and plans to release its first model within six months.
Stanford Study Reveals CAR-T Cell Therapy May Cause Mild Cognitive Impairment in Cancer Patients
A new Stanford University study published in Cell reveals that CAR-T cell therapy can cause mild cognitive impairments or "brain fog" in cancer patients, independent of other treatments.
Orca Bio Appoints Co-Founder Nate Fernhoff as CEO Ahead of 2025 BLA Submission for Orca-T
Orca Bio has appointed co-founder and Chief Scientific Officer Nate Fernhoff, Ph.D., as Chief Executive Officer, succeeding Ivan Dimov, Ph.D.